About us | ExposomeScan

Exposome-Scan is a strategic collaboration between Leiden University (LACDR) and Utrecht University (IRAS) to advance exposome research by offering state-of-the art or even beyond state-of-the-art services to academic, clinical and industrial researchers.

The overall aims of Exposome‐Scan are:

To establish an exposome research facility in the Netherlands for untargeted exposome profiling.
To enable the exploration and investigation of the impact of the exposome on the Dutch population during individual’s life course in existing and future studies (Life Exposome Scan).
To enable the validation of causalities, identification of underlying mechanisms and exploration of interventions in translational in vitro models (Live Exposome Scan).
To yield novel insights that support intervention and prevention strategies extending the healthy lifespan of the Dutch population.

Exposome-Scan is lead by a core team:

Prof. Dr. Thomas Hankemeier

Prof. dr. Bob van de Water

Prof. dr. Roel Vermeulen

Dr. Amy Harms

Dr. Sylvia Le Dévédec

Dr. Robert van Vorstenbosch

Dr. Jelle Vlaanderen

Dr. Ir. Anne-Charlotte Dubbelman

Dr. Esther Zaal

Exposome-Scan

The unique and large-scale open facility Exposome-Scan gives researchers from all over the Netherlands the opportunity to study the exposome. Anyone who submits a good research request will have access to the research facility and will be able to conduct research at Exposome-Scan at cost price. The facility in Leiden opens on 15 February 2024 and builds on the knowledge gained in the Exposome-NL and X-omics research programmes.